GLI1 and acute myeloid leukemia: Another cause of resistance could consist in the association between increased levels of Gli1 and increased levels of UDP glucuronosyltransferase (UGT1A) enzymes, which inactivate drugs by glucuronidation (addition of glucuronic acid) in chemotherapy-resistant AML cells.